These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4130936)

  • 1. [Proceedings: Hormone excretion and cyclus course in various low dosage progestational hormones].
    Tenhaeff D
    Arch Gynakol; 1973 Sep; 214(1):267-8. PubMed ID: 4130936
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunochemical determination of LH during therapy with oral and depot contraceptives].
    Tenhaeff D
    Arch Gynakol; 1971 Jun; 211(1):232. PubMed ID: 4103780
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of ovulation by estrogens.
    Gual C; Becerra C; Rice-Wray E; Goldzieher JW
    Am J Obstet Gynecol; 1967 Feb; 97(4):443-7. PubMed ID: 4163201
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary hormone excretion patterns during low-dose progestogen administration.
    Varga L; Tamme E
    J Int Med Res; 1975; 3(2):63-72. PubMed ID: 1140508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone analytic studies during therapy with new contraceptive agents].
    Tenhaeff D
    Geburtshilfe Frauenheilkd; 1971 Aug; 31(8):760-7. PubMed ID: 4105805
    [No Abstract]   [Full Text] [Related]  

  • 6. Pituitary and ovarian function in women on continuous low dose progestogens; effect of chlormadinone acetate and norethisterone.
    Diczfalusy E; Goebelsmann U; Johannisson E; Tillinger KG; Wide L
    Acta Endocrinol (Copenh); 1969 Dec; 62(4):679-93. PubMed ID: 4188441
    [No Abstract]   [Full Text] [Related]  

  • 7. [The mini pill].
    Kremer J; Bennen J; Huisjes HJ
    Ned Tijdschr Geneeskd; 1969 Dec; 113(52):2324-9. PubMed ID: 4188427
    [No Abstract]   [Full Text] [Related]  

  • 8. Examinations with a monohormonal oral contraceptive agent (continuin).
    Domány Z; Varga A
    Ther Hung; 1975; 23(3):100-4. PubMed ID: 54943
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the effect of oral contraceptives on endocrine function with special reference to luteinising hormone excretion.
    Papanicolaou AD; Loraine JA; Jackson MC
    Acta Endocrinol (Copenh); 1969 Nov; 62(3):477-88. PubMed ID: 4187715
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
    Saunders DM; Marcus SL; Saxena BB; Beling CG; Connell EB
    Fertil Steril; 1971 May; 22(5):332-44. PubMed ID: 4102481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peroral contraception (5): continuing low dosage treatment].
    Larsson-Cohn U
    Lakartidningen; 1970 Jun; 67():Suppl III:56+. PubMed ID: 4097873
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens.
    Larsson-Cohn U; Johansson ED; Wide L; Gemzell C
    Acta Endocrinol (Copenh); 1970 Feb; 63(2):216-24. PubMed ID: 5468622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraception--choice of treatment.
    Law B
    Practitioner; 1977 Oct; 219(1312):571-8. PubMed ID: 594014
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of 0.5 mg lynestrenol on the follicle stimulating hormone, luteinizing hormone, oestrogen and pregnanediol excretion during the menstrual cycle.
    Schmidt-Elmendorff H; Kaiser E; Kopera H
    Arzneimittelforschung; 1969 Aug; 19(8):1277-9. PubMed ID: 5820293
    [No Abstract]   [Full Text] [Related]  

  • 15. OVARIAN INHIBITION WITH PROGESTOGENS: A STUDY OF THE RECUPERATION STAGE.
    PEETERS F; OEYEN R; VANROY M
    Int J Fertil; 1964; 9():111-20. PubMed ID: 14106241
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifertility effects of low dose progestin.
    Rudel HW
    Fed Proc; 1970; 29(3):1228-31. PubMed ID: 4192043
    [No Abstract]   [Full Text] [Related]  

  • 17. ORAL CONTRACEPTION IN PRACTICE.
    JACKSON MC
    J Reprod Fertil; 1963 Aug; 6():153-73. PubMed ID: 14065347
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of a low-oestrogen oral contraceptive on urinary excretion of luteinizing hormone and ovarian steroids.
    Elstein M; Briston PG; Jenkins M; Kirk D; Miller H
    Br Med J; 1974 Jan; 1(5896):11-3. PubMed ID: 4808812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and laboratory experience with a modified low dosage sequential oral contraceptive.
    Wamsteker EF
    Int J Fertil; 1968; 13(4):436-43. PubMed ID: 5700403
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of various dosages of lynestrenol on the FSH, LH and total gonadotrophin activity during the menstrual cycle.
    Schmidt-Elmendorff H
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):368-73. PubMed ID: 5510165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.